We detected several mutated cancer genes involved in PI3K-Akt signaling, cell adhesion, and cell proliferation pathways that were also identified in other DSRCT studies10,39, such as mucin genes and ARID1A. Our multiple-site mutation analysis indicated that most of these secondary mutations in cancer genes were subclonal (i.e., branch mutations). Here, ARID1A is linked to cancer.